Neuroendocrine Disorders



Neuroendocrinology is the science that deals with the interactions between the endocrine and nervous systems in order to maintain different physiological functions of the body, such as homeostasis, reproduction, and energy utilization. The understanding of biological features of neuroendocrine cells, their integration, and different methods of communication has considerably advanced since the neuroendocrinology science was first introduced. In this chapter, we emphasize the modern scope of neuroendocrinology, highlight its future perspectives, and suggest a clinical approach to different neuroendocrine disorders.

Supplementary material

Video 16.1

Gelastic seizure in a child with hypothalamic hamartoma recorded during transport to school. The accompanying attendant asked him why he was laughing (AVI 3377 kb)


  1. 1.
    Scharrer E. Capillaries and mitochondria in neurophil. J Comp Neurol. 1945;83:237–43.PubMedGoogle Scholar
  2. 2.
    Raisman G. An urge to explain the incomprehensible: Geoffrey Harris and the discovery of the neural control of the pituitary gland. Annu Rev Neurosci. 1997;20:533–66.PubMedGoogle Scholar
  3. 3.
    Babiker A, Al Shaikh A. The role of kisspeptin signalling in control of reproduction in genetically similar species. Sudan J Paediatr. 2016;16(1):9–16.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Geracioti TD. Identifying hypothyroidism’s psychiatric presentations. Curr Psychiatr Ther. 2006;5(11):98–117.Google Scholar
  5. 5.
    Babiker AM, Jurayyan NA, Mohamed SH, Abdullah MA. Overview of diagnosis, management and outcome of congenital hypothyroidism: a call for a national screening programme in Sudan. Sudan J Paediatr. 2012;12(2):7–16.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, et al. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med. 2006;3(11):e428.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Zhou JY, Xu B, Lopes J, Blamoun J, Li L. Hashimoto encephalopathy: literature review. Acta Neurol Scand. 2017;135:285–90. Scholar
  8. 8.
    Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab. 2007;91:268–77.PubMedGoogle Scholar
  9. 9.
    Hinton CF, Harris KB, Borgfeld L, Drummond-Borg M, Eaton R, Lorey F, et al. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics. 2010;125(2):S37–47.PubMedGoogle Scholar
  10. 10.
    Mitchell ML, Hsu HW, Sahai I. Massachusetts Pediatric Endocrine Work Group. The increased incidence of congenital hypothyroidism: fact or fancy? Clin Endocrinol. 2011;75(6):806–10.Google Scholar
  11. 11.
    Zoeller RT. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid. 2007;17:811–7.PubMedGoogle Scholar
  12. 12.
    Kambal A. Endemic goitre Darfur, Sudan. MS thesis, University of Khartoum, Sudan. 1969.Google Scholar
  13. 13.
    Omer MIA, Logan RW, Connell MD, Hutchison JH. Thyroid function in cases of endemic goitre in The Sudan. Sudan J Paediatr. 1984;3:26–36.Google Scholar
  14. 14.
    Eltom M, El Mahdi EMA, Salih MAM, Mukhtar E, Omer MIA. A new focus of endemic goitre in the Sudan. Trop Geogr Med. 1985;37:15–21.PubMedGoogle Scholar
  15. 15.
    Eltom M. Endemic goiter in Sudan [dissertation]. Uppsala: Uppsala University; 1993.Google Scholar
  16. 16.
    Eltom M, Salih MAM, Bostrom H, Dahlberg PA. Differences in aetiology and thyroid function in endemic goitre between rural and urban areas of the Darfur Region of the Sudan. Acta Endocrinol. 1985;108:356–60.PubMedGoogle Scholar
  17. 17.
    Medani AM, Elnour AA, Saeed AM. Endemic goitre in the Sudan despite long-standing programmes for the control of iodine deficiency disorders. Bull World Health Organ. 2011;89:121–6.PubMedGoogle Scholar
  18. 18.
    Al Dhaifallah A, Mwanri L, Aljoudi A. Childhood obesity in Saudi Arabia: opportunities and challenges. Saudi J Obes. 2015;3:2–7.Google Scholar
  19. 19.
    AlBuhairan FS, Tamim H, Al Dubayee M, AlDhukair S, Al Shehri S, Tamimi W, et al. Time for an adolescent health surveillance system in Saudi Arabia: findings from “Jeeluna”. J Adolesc Health. 2015;57:263–9.PubMedGoogle Scholar
  20. 20.
    World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series; 2000. pp. 100–142.Google Scholar
  21. 21.
    Lobstein T, Baur L, Uauy R, IASO International. Obesity in children and young people: a crisis in public health. Obes Rev. 2004;5:4–85.PubMedGoogle Scholar
  22. 22.
    Diabetes: facts and figures. International diabetes federation. 2015. Accessed 15 Apr 2017.
  23. 23.
    Hussain AN, Alkhenizan AH, El Shaker M, Raef H, Gabr A. Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia. Arch Osteoporos. 2014;9:190. Epub 2014 Sep 12CrossRefPubMedGoogle Scholar
  24. 24.
    Yu J. Endocrine disorders and the neurologic manifestations. Ann Pediatr Endocrinol Metab. 2014;19:184–90. Scholar
  25. 25.
    Bernal J. Thyroid hormones in brain development and function. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext. South Dartmouth, MA:, Inc.; 2000. Scholar
  26. 26.
    Taylor M, Couto-Silva AC, Adan L, Trivin C, Sainte-Rose C, Zerah M, et al. Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuroophthalmic presenting symptoms. J Pediatr. 2012;161:855–63.PubMedGoogle Scholar
  27. 27.
    Babiker A, Edrees A, Al Gadi I, Al Issa S, Malik S, Al Watedi S, et al. Suprasellar brain tumours related endocrinopathies. ESPE Abstracts. 2015;84: P-3-824Google Scholar
  28. 28.
    Al Rashed A, Al-Jarallah AA, Salih M, Kolawole T, Al-Jarallah J. Sotos syndrome (cerebral gigantism ): a clinical and radiological study of 14 cases from Saudi Arabia. Ann Trop Paediatr. 1999;19:197–203.PubMedGoogle Scholar
  29. 29.
    Gibson WT, Hood RL, Zhan SH, Bulman DE, Fejes AP, Moore R, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet. 2012;90(1):110–8.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Crawford MW, Rohan D. The upper airway in Weaver syndrome. Paediatr Anaesth. 2005;15(10):893–6.PubMedGoogle Scholar
  31. 31.
    Tatton-Brown K, Murray A, Hanks S, Douglas J, Armstrong R, Banka S, et al. Weaver syndrome and EZH2 mutations: clarifying the clinical phenotype. Am J Med Genet A. 2013;161A(12):2972–80.PubMedGoogle Scholar
  32. 32.
    Babiker AM, Al Jurayyan NA, Al Jurayyan RN, Al Gadi I, Drop SL. The clinical pattern of diabetes insipidus in a large university hospital in the Middle East. J Trop Pediatr. 2015;61(2):100–5.PubMedGoogle Scholar
  33. 33.
    Mohamed S, Osman A, Al Jurayyan NA, Al Nemri A, Salih MA. Congenital toxoplasmosis presenting as central diabetes insipidus in an infant: a case report. BMC Res Notes. 2014;7:184. Scholar
  34. 34.
    Bode HH. Disorders of posterior pituitary. In: Kaplan SA, editor. Clinical pediatric and adolescent endocrinology. Philadelphia: WB Saunder; 1996. p. 63–83.Google Scholar
  35. 35.
    Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev. 2000;21:122–9.PubMedGoogle Scholar
  36. 36.
    Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, et al. Diabetes insipidus diagnosis and management. Horm Res Paediatr. 2012;77:69–84.PubMedGoogle Scholar
  37. 37.
    Salih MAM, Tuvemo T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD syndrome). A clinical study in two Sudanese families. Acta Pediatrica Scandinavica. 1991;8:567–72.Google Scholar
  38. 38.
    Al-Herbish AS, Al-Jurayyan NA, Ba Abbad R, Jan M, Salih MAM. Epileptic laughter and precocious puberty due to hypothalamic hamartoma: a case report with review of the literature. Med Sci Res. 1997;25:143–4.Google Scholar
  39. 39.
    Al-Qattan MM, Shamseldin HE, Salih MA, Alkuraya FS. GLI3-related polydactyly: a review. Clin Genet. 2017;92:457–66.PubMedGoogle Scholar
  40. 40.
    Baker JM, Reiss AL. A meta-analysis of math performance in Turner syndrome. Develop Med Child Neurol. 2016;58(2):123–30.PubMedGoogle Scholar
  41. 41.
    Agopiantz M, Corbonnois P, Sorlin A, Bonnet C, Klein M, Hubert N, et al. Endocrine disorders in Woodhouse-Sakati syndrome: asystematic review of the literature. J Endocrinol Investig. 2014;37(1):1–7.Google Scholar
  42. 42.
    Alazami AM, Al-Saif A, Al-Semari A, Bohlega S, Zlitni S, Alzahrani F, et al. Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am J Hum Genet. 2008;83(6):684–91.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Sharma V, Borah P, Basumatary LJ, Das M, Goswami M, Kayal AK. Myopathies of endocrine disorders: a prospective clinical and biochemical study. Ann Indian Acad Neurol. 2014;17:298–302.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Tonner DR, Schlechte JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Am. 1993;77:251–63.PubMedGoogle Scholar
  45. 45.
    Shaw C, Shaw P. Kocher-Debre-Semelaigne syndrome: hypothyroid muscular pseudohypertrophy—a rare report of two cases. Case Rep Endocrinol. 2012;2012:153143.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Al Jurayyan NA, Al Jurayyan RN, Al Senani AM. Efficacy of a high dose of L-thyroxine in the treatment of congenital hypothyroidism. Curr Pediatr Res. 2010;14:125–30.Google Scholar
  47. 47.
    Carmichae SL, Ma C, Ramussen SA, Cunningham ML, Browne ML, Dosiou C, et al. Craniosynostosis and risk factors related to thyroid dysfunction. Am J Med Genet A. 2015;167A(4):701–7. Scholar
  48. 48.
    Papi G, Corsello SM, Pontecorvi A. Clinical concepts on thyroid emergencies. Front Endocrinol (Lausanne). 2014;5:102.Google Scholar
  49. 49.
    Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM. Pediatric manifestations of Hashimoto’s encephalopathy. Pediatr Neurol. 1999;20:394–8.PubMedGoogle Scholar
  50. 50.
    Yu HJ, Lee J, Seo DW, Lee M. Clinical manifestations and treatment response of steroid in pediatric Hashimoto encephalopathy. J Child Neurol. 2013;29:938–42.PubMedGoogle Scholar
  51. 51.
    Chang JS, Chang TC. Hashimoto’s encephalopathy: report of three cases. J Formos Med Assoc. 2014;113:862–6.PubMedGoogle Scholar
  52. 52.
    Salih MAM, Hashem N. Pendred syndrome in a Sudanese family. Sudan J Paediatr. 1978;2:25–34.Google Scholar
  53. 53.
    Hsieh S, White PC. Presentation of primary adrenal insufficiency in childhood. J Clin Endocrinol Metab. 2011;96:E925–8.PubMedGoogle Scholar
  54. 54.
    Choudhary S, Alam A, Dewan V, Yadav D, Dubey NK. An unusual presentation of Addison’s disease: a case report. Clin Pediatr Endocrinol. 2011;20:57–60.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Hinz LE, Kline GA, Dias VC. Addison’s disease in evolution: an illustrative case and literature review. Endocr Pract. 2014;20:e176–9.PubMedGoogle Scholar
  56. 56.
    Hebbar KB, Stockwell JA, Leong T, Fortenberry JD. Incidence of adrenal insufficiency and impact of corticosteroid supplementation in critically ill children with systemic inflammatory syndrome and vasopressor dependent shock. Crit Care Med. 2011;39:1145–50.PubMedGoogle Scholar
  57. 57.
    Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, Hébert PC, et al. A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med. 2010;182:246–51.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Santos L. Stress response in critical illness. Curr Probl Pediatr Adolesc Health Care. 2013;43:264–72.PubMedGoogle Scholar
  59. 59.
    Salpietro V, Polizzi A, Di Rosa G, Romeo AC, Dipasquale V, Morabito P, et al. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol. 2014;2014:282489.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Fenichel GM. Clinical pediatric neurology: a signs and symptoms approach. 4th ed. Philadelphia: W.B. Saunders; 2001.Google Scholar
  61. 61.
    Bergamaschi R, Livieri C, Uggetti C, Candeloro E, Egitto MG, Pichiecchio A, et al. Brain white matter impairment in congenital adrenal hyperplasia. Arch Neurol. 2006;63:413–6.PubMedGoogle Scholar
  62. 62.
    Mnif MF, Kamoun M, Mnif F, Charfi N, Kallel N, Rekik N, et al. Brain magnetic resonance imaging findings in adult patients with congenital adrenal hyperplasia: increased frequency of white matter impairment and temporal lobe structures dysgenesis. Indian J Endocrinol Metab. 2013;17:121–7.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Dincsoy MY, Salih MA, Al-Jurayyan N, Al Saadi M, Patel PJ. Multiple congenital malformations in two sibs reminiscent of hydrocephalus and pseudotrisomy 13 syndromes. Am J Med Genet. 1995;56:317–21.PubMedGoogle Scholar
  64. 64.
    Thukral A, Chitra S, Chakraborty PP, Roy A, Goswami S, Bhattacharjee R, et al. De morseir syndrome presenting as ambiguous genitalia. Indian J Endocrinol Metab. 2012;16(Suppl 2):S509–11.PubMedPubMedCentralGoogle Scholar
  65. 65.
    Gunst J, Van den Berghe G. Blood glucose control in the intensive care unit: benefits and risks. Semin Dial. 2010;23:157–62.PubMedGoogle Scholar
  66. 66.
    Ho J, Mah JK, Hill MD, Pacaud D. Pediatric stroke associated with new onset type 1 diabetes mellitus: case reports and review of the literature. Pediatr Diabetes. 2006;7:116–21.PubMedGoogle Scholar
  67. 67.
    Mulder L, Onur O, Kleis L, Borders H, Cemeroglu AP. Atypical neurologic presentations of new onset type 1 diabetes mellitus in pediatric age group: a report of five unusual cases and review of the literature. J Pediatr Endocrinol Metab. 2014;27:749–56.PubMedGoogle Scholar
  68. 68.
    Ghetti S, Lee JK, Sims CE, Demaster DM, Glaser NS. Diabetic ketoacidosis and memory dysfunction in children with type 1 diabetes. J Pediatr. 2010;156:109–14.PubMedGoogle Scholar
  69. 69.
    Nelson D, Mah JK, Adams C, Hui S, Crawford S, Darwish H, et al. Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes. Pediadtr Diabetes. 7:305–10.Google Scholar
  70. 70.
    Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Investig. 2015;38:1249–63. Scholar
  71. 71.
    Valassi E, Scacchi M, Cavagnini F. Neuroendocrine control of food intake. Nutr Metab Cardiovasc Dis. 2008;18(2):158–68.PubMedGoogle Scholar
  72. 72.
    Agrawal L, Habib Z, Emanuele NV. Neurologic disorders of mineral metabolism and parathyroid disease. Handb Clin Neurol. 2014;120:737–48.PubMedGoogle Scholar
  73. 73.
    Eyal O, Oren A, Juppner H, Somech R, De Bellis A, Mannstadt M, et al. Hypoparathyroidism and central diabetes insipidus: in search of the link. Eur J Pediatr. 2014;173:1731–4.PubMedPubMedCentralGoogle Scholar
  74. 74.
    Damiani D, Aguiar CH, Bueno VS, Montenegro FL, Koch VH, Cocozza AM, et al. Primary hyperparathyroidism in children: patient report and review of the literature. J Pediatr Endocrinol Metab. 1998;11:83–6.PubMedGoogle Scholar
  75. 75.
    AL-Otaibi HM, AL-Jurayyan NAM, Mohamed S, Salih MAM. Osteomalacia in adolescents presenting as proximal myopathy. Curr Pediatr Res. 2012;16(1):57–60.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.King Saud Bin Abdulaziz University for Health Sciences and King Abdullah Specialized Children’s Hospital, Ministry of National Guard Health AffairsRiyadhSaudi Arabia
  2. 2.Division of Pediatric Neurology, Department of Pediatrics, College of Medicine and King Khalid University HospitalKing Saud UniversityRiyadhSaudi Arabia

Personalised recommendations